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Abstract 
 
The objective of the paper was to study the anti-tumor effect of total glycosides from Radix paeoniae rubra in 
S180 tumor-bearing mice, and to preliminarily explore its mechanism of action. Mice were made into S180 solid 
tumor model, grouped and administered with the extracts; tumor inhibition rate was measured by harvesting the 
tumors, and serum IL-2 and IL-4 levels were measured by taking blood samples. Total glycosides of Radix paeoniae 
rubra significantly inhibited the growth of tumor cells in tumor-bearing organisms, enhanced the cytotoxic 
activity of NK cells, and increased the serum IL-2 and IL-4 levels.  Total glycosides of Radix paeoniae rubra have 
some anti-tumor effect in vivo, which might have been accomplished through the regulation of the immune system. 
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Introduction 
 
Radix Paeoniae Rubra (Chishao) is the dried root of Paeonia lactiflora Pall. or Paeonia veitchii Lynch., it is bitter in 
taste, slightly cold, and enters the liver meridian, which has the heat-clearing, blood-cooling, stasis-dissipating and analgesic 
effects (Chinese Pharmacopoeia Commission, 2010). Radix Paeoniae Rubra is mainly grown in provinces such as Inner 
Mongolia, Hebei, Liaoning, Heilongjiang and Jilin of China(Jiangsu New Medical College,1993). Modern pharmacological 
studies have shown that Radix paeoniae rubra has the hepatoprotective(Li et al.,2003), anti-atherosclerotic(Zhu et al.,2003), 
antithrombotic(Xu et al.,2000), anti-platelet aggregation(Xu et al.,2003), hypoglycemic(Zhang et al.,1990) and anti-tumor(Yu 
et al.,2005; Xu et al.,2007&2008) effects. Chemical studies have found that Radix paeoniae rubra contains monoterpene 
glycosides (Kaneda et al.,1972; Nobutoshi et al.,1996), tannins(Makoto et al.,1983), triterpenoids (Kohei et al.,1997) and 
other constituents, of which the main constituent is total glycosides of Chishao (TGC). TGC is an effective component 
extracted from Radix paeoniae rubra, which has a complex chemical composition containing Chishaojiasu, Chishaoyisu, 
benzoic acid, glycosides, etc. In this paper, S180 solid tumor animal model was used to study the anti-tumor effect of TGC. 
 
 
Experimental Materials 
Drugs and reagents 
 
Radix Paeoniae Rubra (Baidu Medicine Co., Ltd.); RPMI l640 medium (GIBCOBRL); MTT, ConA (Sigma); CTX 
(Jiangsu Hengrui Medicine Co., Ltd.); IL-2, IL-4 kit (Beijing Furui Bioengineering Co., Ltd.) 
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Main instruments 
 
AE31 inverted phase contrast microscope (Motic); SW-CJ-IF clean bench (Suzhou Purification Equipment Factory); 
low-temperature refrigerated centrifuge (Eppendorf, Germany); electronic balance (Beijing Sartorius Instrument System Co., 
Ltd.); blood counting chamber (Shanghai Qiujing Biochemical Instrument Factory). 
 
Experimental animals 
 
Kunming mice, half male and half female, weighing 18~22 g, purchased from the Laboratory Animal Center of 
Weifang Medical University. All experimental procedures were approved by the Animal Research Ethics Committee of 
Weifang Medical University, Weifang, China (wf12/01/25). 
 
S180 tumor lines 
 
Purchased from the KeyGEN Biotech Co., Ltd. 
 
Preparation of TGC 
 
Dried Radix paeoniae rubra was crushed with a mortar and pestle, placed in a round bottom flask, added with a 
10-fold volume of ethanol, and heat extracted three times (1.5 h each time), then filtered, the filtrates were combined, and 
solvent was removed until no alcohol smell was present. The concentrated solution was placed in a separating funnel, and 
extracted by adding petroleum ether. The petroleum ether layer was separated, and the remaining layer was extracted several 
times by adding n-butanol, then the n-butanol solutions were combined. Solvent was removed, and the concentrated solution 
was passed through a silica gel column chromatography, and eluted with ethyl acetate solvent, after solvent removal, total 
glycosides of Radix Paeoniae Rubra was obtained, which was stored at 4℃ for later use. 
 
Establishment of animal model (Li et al.,2006) 
 
7 days after inoculation of S180, mice whose abdominal circumferences increased to the maximum were sacrificed 
by cervical dislocation; after abdomen disinfection, abdominal cavities were cut open, and ascites were extracted with 1 mL 
sterile syringes; the ascites were diluted with PBS, centrifuged at 1000 rpm/min for 10 min, then the supernatant was 
discarded. Viable cells were counted using trypan blue staining method, and tumor cell number was adjusted to 1×106 
cells/mL. 40 mice were selected and their right armpit skin was disinfected, tumor cell suspension was 0.2 mL was 
subcutaneously injected into the right forelimb armpit of each mouse using 1 mL sterile syringes to create solid tumor model. 
 
Grouping and treatment 
 
24 h after inoculation, the 40 mice were randomly divided into model group, CTX group, TGC group, and combined 
treatment group (TGC plus CTX), with each group containing 10 mice. Another 10 mice which were not inoculated with 
tumor cells served as the normal control group. All mice were given enough water and food, and mice in each group were 
weighed and their body weights were recorded. CTX group was intraperitoneally injected with 100 mg/kg CTX on the 3rd 
day; dosage in TGC group was 120 mg/kg/d; combined treatment group was intragastrically administered 120 mg/kg/d TGC, 
and intraperitoneally injected with 100 mg/kg CTX on the 3rd day. Mental states, physical activities and feeding status of 
mice were observed daily for seven consecutive days. 
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Determination of tumor inhibition rate 
 
On the 8th day after administration, after weighing, eyeballs were enucleated and blood was sampled from the 
eyeballs, the mice were sacrificed, tumors were harvested and weighed, and tumor inhibition rate was calculated according to 
the following formula. 
Tumor inhibition rate = (average tumor weight of control group - average tumor weight of experimental group) / average 
tumor weight of control group × 100% 
 
Direct in-vitro tumor inhibitory effect of TGC 
 
MTT assay: Ascites rich in S180 cells were taken, washed three times with Hank’s solution, placed in RPMI1640 
complete medium and cultured, cells were passaged once every three days, and cells after three passages were used in the 
experiment. Cells with a density of 5×106 cells/mL were added to each well of 24-well plates, at the same time, different 
concentrations of TGC solutions, with final concentrations of 1.0 mg/ml, 0.8 mg/ml, 0.6 mg/ml, 0.4 mg/ml, 0.2 mg/ml and 0 
mg/ml respectively, were added as well. Total fluid volume of each well was 200 ul, four parallel wells were set up, plates 
were incubated in a 37 ℃, 5% CO2 incubator for 24 h, then 100 ul of supernatant was discarded from each well, 15 ul of 
MTT was added, and the cells were incubated for another 4 h, after that, 100 ul of pure DMSO solution was added to each 
well, and allowed to stand for 20 min, OD value was measured at 570 nm with a microplate reader. 
 
Effect of TGC on NK cell activity in mice 
 
Preparation of mouse splenic lymphocyte suspension was carried out according to the method of Fatima et al. (2006). 
Mice in each group were sacrificed by cervical dislocation, and spleens were harvested under sterile conditions, cut into small 
pieces, disaggregated into a single cell suspension using Medimachine, centrifuged at 1000 r/min for 5 min, then the 
supernatant was discarded. After washing in PBS twice, the cells were prepared into 5×106 cells/mL with RPMI-1640 
medium containing 10% fetal bovine serum, and blown uniformly for later use. 
Serially passaged YAC-1 cells with a concentration of 5×106 cells/mL served as target cells, the effector and target 
cells were incubated in a 37 ℃, 5% CO 2 incubator for 4 h, then added with 10 μL of MTT solution (5 mg/mL), and 
incubated for another 4 h, then centrifuged for 10 min (3000 r/min), supernatant was discarded, and each well was added with 
100 μL of DMSO, after fully shaken, OD value was measured at 570 nm. 
 
Measurement of IL-2 and IL-4 levels in mouse serum 
 
Mice eyeballs were enucleated and blood was sampled from the eyeballs, the blood samples were placed in a 
centrifuge tube, centrifuged at 3000 rpm for 5 min to obtain serum, and measurement was performed according to kit 
instructions and by ELISA method. 
 
Statistical methods 
 
Experimental data were analyzed using the SPSS 13.0 software, comparisons between two groups were performed 
using t-test, and pairwise comparisons among groups were performed using one-way ANOVA. 
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Results 
Effect of TGC on growth of S180 sarcoma in mice in vivo 
 
The results of the effect of TGC on tumor weight and tumor inhibition rate are as shown in Table 1. Daily  
intragastric administration of 120 mg/kg TGC significantly inhibited the growth of tumor cells, where the tumor inhibition 
rate was 40.58%. The effect is better when TGC is used in combination with CTX, where the tumor inhibition rate was 
69.57%, which is not significantly different (P>0.05) than that treated with CTX alone. Tumor inhibition rates in various 
groups, when compared with the model group, all showed significant differences (P<0.05 or P<0.01), suggesting that TGC 
has a significant inhibitory effect on solid tumors in S180 tumor-bearing mice. 
Table 1: Effect of TGC on growth of S180 sarcoma in mice in vivo (
—
X ±S) 
Group Number of animals Tumor weight (g) Tumor inhibition rate 
(%) 
Model group 10 2.07±0.45 - 
CTX group 10 0.71±0.31** 65.70 
TGC group 10 1.23±0.38* 40.58 
Combined treatment 
group 
10 0.63±0.44** 69.57 
Comparison with the model group, * P<0.05; ** P<0.01 
 
Results for the direct in-vitro tumor inhibitory effect of TGC 
 
Cytotoxic effect of TGC on S180 was observed by MTT assay, the results showed that the TGC had no direct 
inhibitory effect on S180 in vitro. 
 
Results for the effect of TGC on NK cell activity in mice 
 
The results for the effect of TGC on NK cell activity in mice are as shown in Table 2. NK cell cytotoxicity in model 
group, when compared with the normal group, was significantly reduced (p<0.05); after treatment with TGC, NK cell 
cytotoxicity improved, which was not significantly different compared with the normal group; CTX  can reduce the 
cytotoxicity of NK cells, no significant difference in cytotoxicity was seen when compared with the model group, and a 
significant decrease of cytotoxicity was seen when compared with the normal group (p<0.01). The combined treatment group  
completely antagonized the immunosuppression caused by CTX, and enhanced the cytotoxic activity of NK cells, which was 
not significantly different compared with the normal group. 
 Table 2: Effect of TGC on NK cell activity in mice (n=10, 
—
X ±S) 
Group NK cytotoxicity/% 
Normal control group 39.34±2.32 
Model group 33.36±1.46* 
CTX group 31.45±1.58** 
TGC group 43.45±3.12☆☆ 
Combined treatment group 38.43±1.87☆ 
Comparison with the normal control group, * P<0.05; ** P<0.01 
Comparison with the model group, ☆P<0.05; ☆☆P<0.01 
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Effect of TGC on serum IL-2 and IL-4 levels in tumor-bearing mice 
 
The effect of TGC on serum IL-2 and IL-4 levels in tumor-bearing mice is as shown in Table 3, compared with the 
normal control group, serum IL-2 level decreased significantly (P<0.05) in mice of model group. After treatment with TGC, 
IL-2 level significantly increased, showing a significant difference (P<0.01) compared with the model group, and no 
significant difference compared with the normal group. IL-2 level in CTX group was significantly lower (P<0.01) than that of 
the normal control group, which was also significantly different (P<0.05) compared with the tumor-bearing control group, 
indicating that the CTX has a relatively strong inhibitory effect; when TGC and CTX were used in combination, IL-2 level 
increased, indicating that the TGC can significantly improve the inhibitory effect of CTX. 
IL-4 level decreased significantly (P<0.05) in model group compared with the normal control group; after treatment 
with TGC, IL-4 level was significantly elevated (P<0.01) compared with the model group; no significant difference was seen 
in IL-4 levels between CTX group and model group; when TGC and CTX were used in combination, inhibitory effect of 
CTX was improved significantly. 
 
Table 3: Effect of TGC on serum IL-2 and IL-4 levels in tumor-bearing mice 
Group Number of animals IL-2（pg/mL）  IL-4（pg/mL）  
Normal control group 10 118.432±5.523 161.356±29.327 
Model group 10 102.563±4.554* 109.873±36.971* 
CTX group 10 94.216±11.358**☆ 113.746±42.198** 
TGC group 10 122.492±13.984☆☆ 173.729±47.614☆☆ 
Combined treatment 
group 
10 114.523±10.573☆ 165.664±42.589☆☆ 
Comparison with the normal control group, * P<0.05; ** P<0.01 
Comparison with the model group, ☆P<0.05; ☆☆P<0.01 
 
 
Discussion 
 
Radix Paeoniae Rubra is an important blood circulation-invigorating and stasis-eliminating traditional Chinese 
medicine, which is often used in combination with other drugs for the treatment of blood stasis syndromes and neoplastic 
diseases, however, the immunological mechanism of its anti-tumor effect and its active constituents are yet to be clarified. It 
can be presumed based on the research results that the TGC may be one of the effective anticancer constituents of Radix 
Paeoniae Rubra. No direct cytotoxic effect of TGC on S180 sarcoma cells was observed in the in-vitro experiment, thus it 
can be inferred that the anti-tumor effect of TGC is accomplished through the regulation of the immune system. Core 
components constituting the immune system are lymphocytes (Soumya and Melanie,2010), which can be divided into T cells, 
B cells and NK cells according to their functions. NK cell (natural killer cell) is a type of cell existing in the body which has 
natural killing ability. Although its cytotoxic activity is weaker than T cells and B cells, but the effect occurs quickly, which is 
one of the body’s important non-specific defense functions. CD4+T cells are divided into Thl cells and Th2 cells since they 
secrete different cytokines, Thl cells mainly secrete IL-2, participate in the cytotoxic T lymphocyte (CTL)-mediated cellular 
immunity, and play a role in the anti-tumor and anti-intracellular infection; Th2 cells mainly secrete IL-4, its function is to 
stimulate B cell proliferation, promote antibody production, participate in humoral immunity and to play a major role in the 
anti-extracellular infection and immune response caused by allergens. The body's anti-tumor immune response involves a 
variety of immune components, and it is generally believed that the cellular immunity plays an important role in the tumor 
Xu et al., Afr J Tradit Complement Altern Med. (2013) 10(3):580-585 
http://dx.doi.org/10.4314/ajtcam.v10i3.29 
585
inhibition. Although CTX has a strong tumor inhibitory effect, it suppresses immune function and lowers immunity at the 
same time, which is not conducive to the control of tumor metastasis and progression. When CTX is used in combination 
with TGC, various indices are all improved to near normal levels, indicating that the TGC can reverse the T cell immune 
suppression and immune dysfunction induced by tumor antigens and CTX, which has a relatively strong immunoregulatory 
effect. 
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